Urethral Dilators Market Size & Share, by Type (Hydraulic Urethra Dilator); Usage (Reusable, Disposable); Application (Meatal Stenosis, Urethral Stricture, Kidney Stone Removal); End-user (Ambulatory Surgical Center, Home Care Settings, Hospitals, Clinics) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 5184
  • Published Date: Aug 23, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Urethral Dilators Market size is expected to cross USD 593 Million by the end of 2035, growing at a CAGR of 6% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of Urethral Dilators was USD 218 Million. The reason behind the growth is impelled by the increasing prevalence of chronic kidney disorders. The prevalence of chronic kidney disease (CKD) has been identified as a major global public health issue, which is majorly caused by stress, and hypertension in all high- and middle-income nations.

Chronic kidney diseases can result in various urological conditions, which involve the use of urethral dilators. Chronic kidney disease (CKD) affects more than 8% of people globally, and millions of people pass away each year because they lack access to effective treatment.

The rising popularity of minimally invasive procedures are believed to fuel the market growth. The popularity of minimally invasive surgery among patients has grown owing to its advantages such as smaller incisions, less discomfort, and shorter hospital stay.

Urethral dilation is a minimally invasive procedure for the treatment of bulbar urethral strictures where a permanent catheter is used to drain the bladder, which offers a faster recovery, and minimal scarring.


Urethral Dilators Market
Get more information on this report: Request Free Sample PDF

Urethral Dilators Sector: Growth Drivers and Challenges

Growth Drivers

  • Spiking Cases of Prostate Cancer – In some cases, prostate cancer may lead to urethral strictures, which necessitate the use of urology devices including urethral dilators to manage urinary function. For instance, depending on the type of cancer treatment used, there is more than a 5% risk of urethral stricture after prostate cancer therapy. In 2020, there were over 1 million new cases of prostate cancer detected worldwide.
  • Growing Geriatric Population- Aged people may have weakened immune systems which can decrease the capacity of the bladder and weaken the pelvic floor muscles. This can lead to several urological disorders, leading to increased demand for urethral dilators. Lately, the number of individuals over 65 across the globe is more than 610 million, or roughly 8% of the population.

Challenges

  • Availability of Alternative Treatment Options – There are many other treatment options such as laser therapies, behavioral therapy, medication, surgical options for rUTI management, and endoscopic or percutaneous are easily available for the treatment of urological condition. This, as a result, limits the adoption of urethral dilators.
  • Stringent Regulatory Standards
  • Lack of Awareness

Urethral Dilators Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~6%

Base Year Market Size (2022)

~ USD 0.218 Billion

Forecast Year Market Size (2035)

~ USD 0.593 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Urethral Dilators Segmentation

Usage (Reusable, Disposable)

The disposable segment is estimated to gain a robust market share of 62% in the coming years owing to the benefits offered. Disposable urethral dilators are designed for single use with consistent quality standards. They don’t require any sterilization which reduces the risk of cross-contamination between patients. In addition, these dilators are cost-effective as compared to reusable dilators and can be easily disposed of.

Application (Meatal Stenosis, Urethral Stricture, Kidney Stone Removal)

The urethral stricture segment in the urethral dilators market is set to garner a notable share of 51% shortly on the account of growing surgical procedures. Surgical procedures involve the repeated use of catheters which may cause irritation or swelling and scar tissue formation, which can restrict the urethra and cause urine to back up in the urinary tract, resulting in urethral stricture. This can be treated by using the urethral dilation technique where a doctor puts a very little wire into the bladder through the urethra by stretching the urethra's sidewalls. Every year, more than 300 million major surgical procedures are carried out worldwide.

Our in-depth analysis of the global market includes the following segments:

  Usage

  • Reusable
  • Disposable

  Application

  • Meatal Stenosis
  •  Urethral Stricture
  •  Kidney Stone Removal

  End-User

  • Ambulatory Surgical Center
  •  Home Care Settings
  •  Hospitals
  •  Clinics

   Type

  • Hydraulic Urethra Dilator

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Urethral Dilators Industry- Regional Synopsis

North American Market Forecast

Urethral dilators market in North America is predicted to account for the largest share of 38% by 2035 impelled by the growing spending in healthcare. As a result, more efficient and advanced medical technologies including urethral dilators are expected to develop in the region. In addition, availability of more resources would also improve the medical access, which may result in a higher number of surgeries that may require urethral dilators. In 2021, health spending in the US increased by over 2%.

APAC Market Statistics

The APAC urethral dilators market is estimated to be the second largest, during the forecast timeframe led by rapidly growing medical tourism. India's medical tourism industry is expanding, since there are many different travel choices available in the country such as its low-cost treatments and state-of-the-art medical facilities. This has significantly increased the demand for urethral dilators as people from different regions visit India and other Asia Pacific countries for urological treatments.

For instance, more than a million individuals from over 75 different countries travel to India each year for medical, wellness, and IVF procedures. As a result, the demand for urethral dilators may rise in the region as more people can access medical facilities for the treatment of urological conditions.

Research Nester
Urethral Dilators Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Urethral Dilators Landscape

top-features-companies
    • Cook Medical LLC
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • B. Braun Melsungen AG
    • Guangzhou Weili Medical Equipment Co. Ltd.
    • Manish Medi Innovation
    • MED pro Medical BV
    • Medi Globe Technologies GmbH
    • Coloplast
    • SEPLOU Inc.
    • Teleflex Inc.
    • Zhejiang Chuangxiang Medical Technology Co. Ltd
    • Boston Scientific Corporation

In the News

  • Coloplast introduced New Catheter, SpeediCath Flex Set with Triple Action Coating Technology, for people living with bladder and urinary problems to enhance their catheterization procedures in a variety of ways, and to lower the risk of urethral injury and urinary tract infections (UTIs).
  • Boston Scientific Corporation received approval from the U.S. Food and Drug Administration (FDA) for its POLARx Cryoablation System which uses the POLARx FIT Cryoablation Balloon Catheter, to treat patients with paroxysmal atrial fibrillation (AF).

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5184
  • Published Date: Aug 23, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing prevalence of chronic kidney disorders and the rising popularity of minimally invasive procedures are the major factors driving the growth of the market.

The market size of Urethral Dilators is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Enfucell Oy, STMicroelectronics International N.V., LG Chem, Ltd., Cymbet Corporation, Imprint Energy Inc, Jenax Inc., Samsung SDI Co., Ltd., Excellatron Solid State, LLC, and others.

The disposable segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Urethral Dilators Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying